Grantham, Mayo, Van Otterloo & Co (GMO)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$564M Sell
1,938,276
-592,814
-23% -$195M 1.44% 26
2025
Q4
$887M Buy
2,531,090
+7,640
+0.3% +$2.58M 2.27% 15
2025
Q3
$815M Buy
2,523,450
+483,340
+24% +$150M 2.3% 17
2025
Q2
$794M Sell
2,040,110
-118,881
-6% -$47.8M 2.39% 13
2025
Q1
$939M Buy
2,158,991
+158,331
+8% +$63.6M 2.96% 9
2024
Q4
$738M Buy
2,000,660
+316,002
+19% +$132M 2.4% 13
2024
Q3
$876M Buy
1,684,658
+334,790
+25% +$179M 2.75% 9
2024
Q2
$731M Buy
1,349,868
+102,603
+8% +$54.2M 2.47% 11
2024
Q1
$647M Buy
1,247,265
+328,504
+36% +$163M 2.35% 13
2023
Q4
$433M Buy
918,761
+28,849
+3% +$13.3M 1.91% 16
2023
Q3
$387M Buy
889,912
+59,071
+7% +$26.8M 1.83% 13
2023
Q2
$369M Buy
830,841
+112,802
+16% +$52M 1.71% 15
2023
Q1
$330M Buy
718,039
+9,196
+1% +$4.38M 1.68% 14
2022
Q4
$364M Sell
708,843
-5,299
-0.7% -$2.69M 1.94% 9
2022
Q3
$324M Sell
714,142
-15,466
-2% -$7.4M 1.87% 10
2022
Q2
$352M Sell
729,608
-202,938
-22% -$100M 1.91% 11
2022
Q1
$458M Sell
932,546
-169,482
-15% -$77.5M 2.21% 8
2021
Q4
$511M Sell
1,102,028
-39,818
-3% -$16.8M 2.45% 11
2021
Q3
$426M Buy
1,141,846
+96,566
+9% +$36.7M 2.11% 11
2021
Q2
$399M Buy
1,045,280
+10,053
+1% +$3.84M 1.99% 12
2021
Q1
$372M Buy
1,035,227
+10,920
+1% +$3.51M 2.03% 13
2020
Q4
$329M Sell
1,024,307
-8,800
-0.9% -$2.7M 2.02% 13
2020
Q3
$277M Buy
1,033,107
+16,191
+2% +$4.36M 1.97% 13
2020
Q2
$267M Buy
1,016,916
+3,894
+0.4% +$1.04M 1.99% 13
2020
Q1
$230M Buy
1,013,022
+35,945
+4% +$9.8M 1.92% 13
2019
Q4
$295M Sell
977,077
-32,331
-3% -$8.9M 1.97% 15
2019
Q3
$242M Buy
1,009,408
+58,411
+6% +$16M 1.68% 17
2019
Q2
$268M Buy
950,997
+139,993
+17% +$38.2M 1.89% 14
2019
Q1
$233M Sell
811,004
-116,933
-13% -$33.8M 1.67% 18
2018
Q4
$244M Sell
927,937
-99,841
-10% -$27.5M 1.95% 16
2018
Q3
$282M Sell
1,027,778
-85,282
-8% -$22.1M 1.91% 14
2018
Q2
$265M Sell
1,113,060
-150,323
-12% -$34.8M 1.88% 15
2018
Q1
$278M Buy
1,263,383
+306,876
+32% +$72.1M 1.7% 19
2017
Q4
$215M Sell
956,507
-66,251
-6% -$14.1M 1.27% 24
2017
Q3
$194M Sell
1,022,758
-72,809
-7% -$13.9M 1.14% 25
2017
Q2
$206M Buy
1,095,567
+463,020
+73% +$83.2M 1.14% 23
2017
Q1
$105M Sell
632,547
-68,988
-10% -$11M 0.59% 43
2016
Q4
$101M Sell
701,535
-78,271
-10% -$10.5M 0.54% 44
2016
Q3
$97.7M Sell
779,806
-350,671
-31% -$45.3M 0.46% 51
2016
Q2
$148M Buy
1,130,477
+15,025
+1% +$2.06M 0.61% 38
2016
Q1
$155M Buy
1,115,452
+211,000
+23% +$28.2M 0.58% 42
2015
Q4
$126M Buy
904,452
+4,857
+0.5% +$669K 0.45% 56
2015
Q3
$126M Buy
899,595
+255,859
+40% +$38.5M 0.44% 52
2015
Q2
$106M Buy
643,736
+518,634
+415% +$82.9M 0.34% 64
2015
Q1
$19.3M Sell
125,102
-97,747
-44% -$13.9M 0.06% 139
2014
Q4
$28M Sell
222,849
-780,265
-78% -$96.4M 0.08% 121
2014
Q3
$120M Sell
1,003,114
-489,652
-33% -$56.2M 0.32% 57
2014
Q2
$161M Sell
1,492,766
-488,800
-25% -$50.4M 0.44% 47
2014
Q1
$197M Buy
1,981,566
+367,722
+23% +$33.3M 0.51% 41
2013
Q4
$149M Buy
1,613,844
+936,942
+138% +$83.3M 0.36% 56
2013
Q3
$56.6M Buy
676,902
+258,709
+62% +$22.2M 0.15% 78
2013
Q2
$34.2M Buy
+418,193
New +$31.3M 0.09% 91

Other funds holding ELV